Cargando…
Intra- and Inter-Tumor BRAF Heterogeneity in Acral Melanoma: An Immunohistochemical Analysis
The current development of BRAF inhibitors has revolutionized the treatment of unresectable melanoma. As the potential heterogeneity of BRAF mutations in melanoma has been reported, accurate detection of BRAF mutations are important. However, the genetic heterogeneity of acral melanoma—a distinct ty...
Autores principales: | Ito, Takamichi, Kaku-Ito, Yumiko, Murata, Maho, Ichiki, Toshio, Kuma, Yuki, Tanaka, Yuka, Ide, Taketoshi, Ohno, Fumitaka, Wada-Ohno, Maiko, Yamada, Yuichi, Oda, Yoshinao, Furue, Masutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941107/ https://www.ncbi.nlm.nih.gov/pubmed/31817947 http://dx.doi.org/10.3390/ijms20246191 |
Ejemplares similares
-
Immunohistochemical BRAF V600E Expression and Intratumor BRAF V600E Heterogeneity in Acral Melanoma: Implication in Melanoma-Specific Survival
por: Ito, Takamichi, et al.
Publicado: (2020) -
Preoperative Screening CT and PET/CT Scanning for Acral Melanoma: Is it Necessary?
por: Ide, Taketoshi, et al.
Publicado: (2021) -
Narrow-Margin Excision for Invasive Acral Melanoma: Is It Acceptable?
por: Ito, Takamichi, et al.
Publicado: (2020) -
NECTIN4 Expression in Extramammary Paget’s Disease: Implication of a New Therapeutic Target
por: Murata, Maho, et al.
Publicado: (2020) -
Nectin Cell Adhesion Molecule 4 (NECTIN4) Expression in Cutaneous Squamous Cell Carcinoma: A New Therapeutic Target?
por: Tanaka, Yuka, et al.
Publicado: (2021)